tiprankstipranks
Alaunos Therapeutics (TCRT)
NASDAQ:TCRT

Alaunos Therapeutics (TCRT) Financial Statements

657 Followers

Alaunos Therapeutics Financial Overview

Alaunos Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.322; its P/E ratio is -0.78; Alaunos Therapeutics is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue-$ 4.00K-$ -11.00K$ 2.91M
Gross Profit-$ 4.00K-$ -11.00K-
EBIT$ -6.45M$ -8.20M$ -9.20M$ -7.57M$ -8.01M
EBITDA$ -5.78M$ -6.63M$ -8.03M$ -6.49M$ -7.32M
Net Income Common Stockholders$ -6.45M$ -8.77M$ -10.05M$ -9.88M$ -8.85M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 11.94M$ 18.32M$ 37.43M$ 53.00M$ 37.81M
Total Assets$ 19.44M$ 27.93M$ 48.64M$ 64.94M$ 67.34M
Total Debt$ 1.17M$ 1.56M$ 13.60M$ 19.51M$ 25.54M
Net Debt$ -10.77M$ -16.75M$ -23.83M$ -33.48M$ -12.26M
Total Liabilities$ 5.54M$ 6.28M$ 19.13M$ 26.38M$ 35.23M
Stockholders Equity$ 13.90M$ 21.65M$ 29.51M$ 38.55M$ 32.11M
Cash Flow-
Free Cash Flow$ -6.37M$ -7.14M$ -9.40M$ -7.22M$ -6.16M
Operating Cash Flow$ -6.37M$ -7.00M$ -9.38M$ -7.13M$ -6.14M
Investing Cash Flow$ 1.00K$ -135.00K$ -23.00K$ -93.00K$ -14.00K
Financing Cash Flow-$ -11.98M$ -6.16M$ 8.47M$ -2.11M
Currency in USD

Alaunos Therapeutics Earnings and Revenue History

Alaunos Therapeutics Debt to Assets

Alaunos Therapeutics Cash Flow

Alaunos Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis